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Background: Neonatal sepsis is a worldwide public health issue in which, depending on the studied population,
marked variations concerning its risk and prognostic factors have been reported. The aim of this study was to
assess risk and prognostic factors for neonatal sepsis prevailing at a medical unit in southeastern Mexico. Thus, we
used a historic cohort design to assess the association between a series of neonates and their mothers, in addition
to hospital evolution features and the risk and prognosis of neonatal sepsis (defined by Pediatric Sepsis Consensus
[PSC] criteria) in 11,790 newborns consecutively admitted to a Neonatology Service in Mérida, Mexico, between
2004 and 2007.
Results: Sepsis was found in 514 of 11,790 (4.3 %) newborns; 387 of these cases were categorized as early-onset
(<72 h) (75.3 %) and 127, as late-onset (>72 h) (24.7 %). After logistic regression, risk factors for sepsis included the
following: low birth weight; prematurity; abnormal amniotic fluid; premature membrane rupture (PMR) at >24 h;
respiratory complications, and the requirement of assisted ventilation, O2 Inspiration fraction (IF) >60 %, or a
surgical procedure. Some of these factors were differentially associated with early- or late-onset neonatal sepsis. The
overall mortality rate of sepsis was 9.5 %. A marked difference in the mortality rate was found between early- and
late-onset sepsis (p >0.0001). After Cox analysis, factors associated with mortality in newborns with sepsis
comprised the following: prematurity; low birth weight; low Apgar score; perinatal asphyxia, and the requirement of
any invasive medical or surgical procedure.
Conclusions: The incidence of neonatal sepsis in southeastern Mexico was 4.3 %. A different risk and prognostic
profile between early- and late-onset neonatal sepsis was found.
Keywords: Neonatal sepsis, Early-onset neonatal sepsis, Late-onset neonatal sepsis, Risk factors, Prognostic factors,
MortalityBackground
Worldwide, the neonatal mortality rate has been set at
30/1,000, resulting in 4 million deaths each year; 95 % of
these deaths occurs in developing countries, where the
risk of neonatal death is 6 times higher than that of
developed countries [1-3]. The leading causes of neo-
natal mortality are infections, followed by asphyxia and* Correspondence: yelda_leal03@yahoo.com.mx
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reproduction in any medium, provided the orcongenital abnormalities [4-6]. Thus, neonatal sepsis is a
relevant public health issue because it consistently
emerges as one of the main causes of neonatal morbidity
and mortality.
In Mexico, the National Institute for Statistics and
Geography (INEGI) reported that neonatal diseases were
the first cause (49.8 %) of deaths in children <1 year of
age, neonatal sepsis was again found as one of its main
specific causes [7,8], and the incidence of neonatal sepsis
in 2003 was reported as between 4 and 14 15.4/1,000
live newborns [9]. In Yucatán, a state in southeastern
Mexico, a study performed between 2000 and 2004 at. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Microbiological profile found in blood culture
from neonates with early- and late-onset sepsis
Isolated microorganism Early- onset Late- onset
N= 387 N=127
Escherichia coli 1 2
Klebsiella pneumoniae 1 4
Enterobacter cloacae 0 3
Pseudomonas spp. 0 3
Haemophilus influenzae 0 1
Streptococcus group B 2 2
Staphylococcus aureus 0 13
Staphylococcus CoNS 5 37
Candida spp. 0 13
Total 9 78
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tute of Social Security (IMSS) in Mérida, the neonatal
mortality rate was 10.3/1,000 [10].
Despite recent advances in neonatal care, the impact
of neonatal sepsis remains marked in developing coun-
tries [1,11,12]. Thus, identifying the risk and prognosis
factors prevailing in the different geographical contexts
has become a crucial issue for optimizing neonatal care.
Because there is scarce information on these topics in
the geographical context in which the study was carried
out, we performed a retrospective study in newborns be-
tween 2004 and 2007 that was aimed at assessing the as-
sociation between neonates and maternal clinical and
demographical factors, in addition to clinical course fea-
tures and the risk for neonatal sepsis.
We categorized sepsis as early-onset when the diagno-
sis was performed prior to 72 h in the life of the neonate
and late-onset if the diagnosis was carried out after this
deadline. Usually, early-onset neonatal sepsis is asso-
ciated with perinatal background and late-onset is
mainly related with the medical and surgical invasive
procedures required by neonates who already have the
disease [4,13-15]. Our results supported this statement,




A total of 11,790 newborns (males, 6,013; females: 5,775;
two, unclassified gender) were admitted to the partici-
pating Neonatology wards during the study period. The
entire cohort totaled 50,900 follow-up days and
4.2 ± 14.6 follow-up days per patient (range, 1–142
follow-up days).
Sepsis was found in 514 (4.3 %) neonates, and
appeared as early-onset in 387 and as late-onset in 127
neonates. Sepsis, defined as the microbial isolation of
any biological sample, was found in 87 neonates
(16.9 %); 9 were from early-onset and 78 from late-onset
sepsis. The microbiological profile was as follows: Gram-
positive bacteria [mainly Coagulase-Negative Staphylo-
coccus Group (CoNS)] were identified in 59 (67.8 %)
patients; Gram-negative bacteria (mainly Klebsiella spp.)
were isolated in 15 (17.2 %), and Candida spp. was
found in 13 (14.9 %) patients (Table 1).
Neonates with sepsis accounted for 12,884 follow-up
days (mean, 25.0 ± 29.3 follow-up days per patient; range,
1–277 follow-up days), which was significantly longer
when compared with neonates without sepsis (3.3 ± 12.6
patient/day) p <0.0001.
The final outcome in the entire group of neonates with
sepsis was as follows: 444 (86.4 %) were rated as healthy
neonates, 21 (4.1 %) were discharged from the hospital
with some type of residual damage, and 49 (9.5 %) died.Among neonates with early-onset sepsis, 353 were dis-
charged from the hospital as healthy neonates, 12
(3.1 %) had some type of sequelae, and a fatal outcome
was registered in 22 (5.7 %) neonates. On the other hand,
prognosis of late-onset neonatal sepsis was poorer because
death was registered in 27 (21.3 %) neonates (p <0.0001),
91 (71.7 %) were discharged from the hospital as healthy
neonates, and nine (7.1 %) neonates left the hospital with
some type of residual damage. Furthermore, neonates with
late-onset sepsis had longer hospital stays (48.1 ± 39.0 days)
as compared with those of neonates with early-onset sep-
sis (17.4 ± 19.9 days) p <0.0001.Risk assessment for neonatal sepsis
Comparison of the clinical and demographic features of
the newborns, their mothers, and clinical-course charac-
teristics by univariate analysis between the entire group
of neonates with and without sepsis is depicted in
Table 2. Of all of these, only neonate gender, post matur-
ity, low maternal educative level, and preeclampsia
appearing after 35 gestational weeks were not entered
into the multivariable analysis. After logistic regression
analysis, only low birth weight (≤2,500 g) RR = 1.0, 95 %
CI = 1.0-1.0, p ≤ 0.0001; prematurity (≤37 wks) RR = 2.4,
95 % CI = 1.7-3.4, p ≤ 0.0001; abnormal amniotic fluid
RR= 1.5, 95 % CI = 1.1-1.9, p ≤ 0.005; premature mem-
brane rupture (PMR) >24 h RR= 3.5, 95 % CI = 1.8-6.6,
p ≤ 0.0001; the emergence of any respiratory complica-
tion after birth RR= 35.0, 95 % CI = 22.1-57.1, p≤ 0.001;
and the requirements of assisted ventilation RR= 1.7,
95 % CI = 1.1-2.5, p ≤ 0.004; O2IF >60 % RR= 3.2, 95 %
CI = 2.1-4.9; p ≤ 0.001; or any type of surgical procedure
RR= 9.6, 95 % CI = 3.3-27.7, p ≤ 0.0001; were identified
as independent risk factors for sepsis.
When the risk analysis was focused on early-onset sep-
sis, the independent risk factors comprised; prematurity,
Table 2 Comparison of all collected data between






N=514 (%) N=11276 (%)
Neonate-related
Gender (feminine/masculine) 233/281 5542/5732 0.22
Gestational age (wk)* 34 ± 4.3 39 ± 2.3 <0.0001
Birth weight (g)* 2069 ± 837 3053± 576 <0.0001
Height (cm)* 43.4 ± 5.9 49.3 ± 3.3 <0.0001
Premature (≤37 wks) 350 (68.1) 1581 (14.0) <0.0001
Postmature (≥42 wks) 5 (1.0) 131 (1.2) 0.45
Product of multiple pregnancy 41 (8.0) 204 (1.8) <0.0001
Abnormal umbilical cord 131 (25.5) 1620 (14.4) <0.0001
With perinatal asphyxia 17 (3.3) 81 (0.7) <0.0001
With intrauterine hypoxia 10 (1.9) 71 (0.6) 0.003
Apgar score ≤5 274 (53.3) 1,765 (15.7) <0.0001
With fetal distress 86 (16.7) 896 (7.9) <0.0001
Maternal-related
Age (yrs)* 26 ± 5.5 25 ± 5.4 0.10
Low educative level 284 (55.3) 6341 (56.2) 0.341
Gestations* 2 ± 1.2 2 ± 1.1 0.01
Deliveries* 0.5 ± 0.9 0.6 ± 0.9 0.001
Non-adequate pregnancy
control
258 (50.2) 4112 (36.5) <0.0001
Experienced threat of abortion
during this pregnancy
139 (27.0) 1905 (16.9) <0.0001
Abnormal placenta 86 (16.7) 436 (3.9) <0.0001
Dystocic delivery 151 (24.9) 5900 (52.3) <0.0001
Cesarean section 359 (69.8) 5232 (46.4) <0.0001
Abnormal amniotic fluid 159 (30.9) 1687 (15.0) <0.0001
Premature membrane
rapture> 12 h
168 (32.7) 469 (4.2) <0.0001
Premature membrane
rapture> 24 h
137 (26.7) 222 (2.0) <0.0001
Premature membrane
rapture> 48 h
85 (26.7) 105 (0.9) <0.0001
Amnionitis 4 (0.8) 32 (0.3) 0.074
Preeclampsia ≤35
gestational wks
28 (5.4) 340 (3.0) <0.0001
Preeclampsia >35
gestational wks
26 (5.1) 569 (5.0) 0.530
Metabolic disease ≤35
gestational wks
27 (5.3) 326 (2.9) 0.002
Metabolic disease >35
gestational wks
26 (5.1) 343 (3.0) 0.007
Infectious disease ≤35
gestational wks
164 (31.9) 2793 (24.8) <0.0001
Infectious disease >35
gestational wks
79 (15.4) 1270 (11.3) 0.003
Table 2 Comparison of all collected data between
neonates with and without sepsis (univariate analysis)
(Continued)
Clinical-course and medical-care related
Reanimation required 339 (66.0) 3888 (34.5) <0.0001
Mechanical ventilation
required
160 (31.1) 209 (1.9) <0.0001
O2 inspiration fraction
required> 60 %
95 (18.5) 96 (0.9) <0.0001
Continuous positive
airway pressure required
24 (4.7) 14 (0.01) <0.0001
Surfactant administration 49 (9.5) 34 (0.3) <0.0001
Respiratory complication 35 (6.8) 91 (0.8) <0.0001
Intraventricular bleeding 20 (3.9) 28 (0.2) <0.0001
Surgical procedure required 14 (2.7) 10 (0.1) <0.0001
Medical procedure required 293 (57.0) 609 (5.4) <0.0001
*Mean± Standard deviation (SD).
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malities, the emergence of respiratory disease, and the
requirement of any medical procedure (Table 3).
On the other hand, independent risk factors for late-
onset sepsis after logistic regression included postmatur-
ity (≥42 wks), perinatal asphyxia, multiple pregnancy,
the emergence of any type of postnatal respiratory dis-
ease, and requirement of assisted ventilation, O2IF
>60 %, positive intermittent pressure, or any other type
of medical or surgical procedure (Table 3).
Mortality-associated factors
The results of the univariate analysis comparing all col-
lected data between deceased and surviving neonates
with sepsis are depicted in Table 4. Multivariate analysis
was conducted on all of these. After Cox proportional
hazard analysis, only prematurity, low birth weight, peri-
natal asphyxia, low Apgar score at birth, and the re-
quirement of assisted ventilation or invasive medical or
surgical procedures during the hospital stay emerged as
independent factors for mortality (Table 5).
Discussion
The incidence of neonatal sepsis varies among the differ-
ent geographic areas, the highest being registered in Af-
rica and Asia (23-38/1,000 live births) and the lowest, in
countries such as the U.S. and Australia (range, 1.5-3.5
/1,000 live births). In South America and the Caribbean,
the incidence of neonatal sepsis ranges between 3.5 and
8.9/1,000 live births [12], while in Mexico, the reported
rates range between 4 and 15.4/1,000 live births [9]. Al-
though the neonatal mortality rate has been documented
in our southeastern Mexico region, the incidence of sep-
sis and its associated factors remain unknown. The
present study was carried out with a population cohort
Table 3 Variables that retained statistical significance in risk for neonatal sepsis after logistic regression
Variable Early-onset Late-onset
RR (95 % CI) P RR (95 % CI) P
Neonate-related factors
Low birth weight (≤2500 g) 0.91 0.63-1.32 0.642 1.34 0.74-2.42 0.326
Prematurity (≤37 wks) 2.19 1.41-3.40 <0.0001 1.35 0.57-3.18 0.487
Product of multiple pregnancy 1.13 0.64-1.98 0.669 2.5 1.14-4.80 0.019
Abnormal amniotic fluid 1.67 1.25-2.23 0.007 —— ——— ——
Abnormal umbilical cord 1.21 0.89-1.63 0.207 1.15 0.69-1.92 0.584
Perinatal asphyxia 0.78 0.26-2.32 0.656 5.15 1.92-13.83 0.001
Maternal-related factors
PMR ≥24 h¥ 3.38 1.80-6.32 <0.0001 2.71 0.48-15.30 0.258
Abnormal placenta 1.71 1.16-2.53 0.007 1.17 0.94-3.22 0.078
Medical-care and hospital-evolution derived factors
Mechanical ventilation 1.00 0.90-1.12 0.863 2.71 1.56-4.69 <0.0001
O2 inspiration fraction >60 % 3.21 1.95-5.28 <0.0001 2.85 1.57-5.15 0.001
Continuous positive airway pressure 0.87 0.29-2.60 0.804 3.66 1.30-10.27 0.013
Respiratory complication 42.48 25.53-70.67 <0.0001 16.36 3.39-78.91 <0.0001
Surgical procedure required 2.98 0.62-4.37 0.173 28.97 6.99-120.01 <0.0001
Invasive medical procedure required 3.01 2.13-4.26 <0.0001 12.5 6.37-24.56 <0.0001
RR, Relative Rate; 95 % CI, 95 % Confidence interval; PMR¥, Premature membrane rupture.
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births. A total of 514 neonates were found with sepsis,
of which 87 cases were confirmed by means of blood
culture; this low sensitivity of the blood culture can be
due to the logistical problems involved in culturing very
small quantities of blood [16]. Despite that blood culture
is considered the gold standard in the diagnosis of sep-
sis, it is a technique with a low sensitivity, because under
optimal conditions, only 5-10 % of suspected cases of
sepsis can be confirmed [2,17,18]. In a retrospective
study with 21,771 registries (Mclntire, et al.), only 0.3 %
of cases of sepsis were confirmed by blood culture [19].
On the other hand, Cohen-Wolkowiew, et al., in a multi-
center study performed between 1997 and 2007 in which
119,130 premature newborns from Intensive care units
(ICU) were included, documented that 69 % of these
had at least one request for blood culture; however, only
0.4 % were confirmed by culture. These authors suggest
that the incidence of sepsis can be low in premature
newborns because only a small number achieved con-
firmation [20]. Due to that the majority of neonates with
sepsis were premature (68.1 %), it is difficult to deter-
mine whether the diagnosis of sepsis based on clinical
signs can be confused with prematurity at birth, given
that the specific pathophysiology of the sepsis in the pre-
mature neonate includes alterations of the immature
myocardium and immaturity of the immunological and
autonomous nervous systems [21,22].In our study, the majority of episodes of sepsis (387/
514) were documented during the first 3 days of life
(early-onset) with a mortality rate of 5.7 %; furthermore,
the isolation of infecting microorganism was low 2.3 %
(9 isolations) and Staphylococcus CoNS were the most
commonly isolated microorganisms, while for late-onset
sepsis we documented a lower incidence (127/514), but
a higher lethality (21.3 %), Staphylococcus CoNS,
Staphylococcus aureus and Candida ssp. were the most
frequently isolated microorganisms. Currently in the lit-
erature, there is no consensus on temporality and type
of sepsis; for example, early-onset sepsis can be defined
by a period ranging from birth to 48 h or until 6 days of
life; this discrepancy affects the interpretation of the
rates reported and renders comparison difficult among
the different studies. For example, in a study carried out
in Kenya in which early-onset sepsis is considered at
≤3 days of life, the authors documented a mortality of
4 % in early-onset and of 10 % in late-onset sepsis; the
most commonly isolated microorganisms were Klebsiella
spp. and Citrobacter spp. [23]. In Panama, the authors
reported a mortality of early-onset sepsis of 44 % and
one of 22 % for late-onset sepsis, with Klebsiella spp.
and Staphylococcus aureus as the most commonly iso-
lated microorganisms; the authors considered early-
onset sepsis as ≤5 days of life [24]. In India, where early-
onset sepsis is considered up to ≤6 days of life, the
authors found a mortality of 49 vs. 86 % in late-onset
Table 4 Comparison of all collected data between
deceased and surviving septic neonates (univariate
analysis)
Variable Deceased Surviving P
N=49 (%) N=465 (%)
Neonate-related
Gender (feminine/masculine) 21/28 212/253 0.41
Gestational age (wk)* 31.3 ± 5.2 34.0 ± 4.1 <0.0001
Birth weight (g)* 1486 ± 867 2130± 852 <0.0001
Height (cm)* 38.2 ± 6.2 44.0 ± 5.6 <0.0001
Premature (≤37 wks) 38 (77.5) 153 (32.2) 0.08
Postmature (≥42 wks) 1 (2.0) 4 (0.9) 0.39
Product of multiple pregnancy 7 (14.3) 34 (7.3) 0.08
Abnormal umbilical cord 14 (28.6) 117 (25.2) 0.35
With perinatal asphyxia 9 (18.4) 8 (1.7) <0.0001
With intrauterine hypoxia 3 (6.1) 7 (1.5) 0.06
Apgar score ≤5 42 (85.7) 232 (49.9) <0.0001
With fetal distress 13 (26.5) 73 (15.7) 0.04
Maternal-related
Age (yrs)* 27.0 ± 5.8 26.3 ± 5.5 0.42
Low educative level 26 (53.1) 258 (55.5) 0.43
Gestations* 2.3 ± 1.3 1.9 ± 1.2 0.06
Abortions* 0.4 ± 0.7 0.2 ± 0.5 0.01
Non-adequate pregnancy
control
30 (61.2) 228 (49.0) 0.07
With threat of abortion
during this pregnancy
19 (38.8) 120 (25.8) 0.04
Abnormal placenta 15 (30.6) 71 (15.3) 0.008
Abnormal amniotic fluid 20 (40.8) 139 (29.9) 0.08
Dystocic delivery 16 (32.7) 135 (29.0) 0.35
Cesarean section 32 (65.3) 327 (70.3) 0.28
Premature membrane
rupture >12 h
10 (20.4) 158 (34.0) 0.03
Premature membrane
rupture >48 h
7 (14.3) 130 (28.0) 0.02
Premature membrane
rupture >24 h
5 (10.2) 80 (17.2) 0.14
Amnionitis 0 4 (0.9) 0.66
Preeclampsia ≤35
gestational wks
3 (6.1) 25 (5.4) 0.51
Preeclampsia >35
gestational wks
2 (4.1) 24 (5.2) 0.54
Metabolic disease ≤35
gestational wks
4 (8.2) 23 (4.9) 0.25
Metabolic disease >35
gestational wks
1 (2.0) 25 (5.4) 0.26
Infectious disease ≤35
gestational wks
17 (34.7) 147 (31.6) 0.38
Infectious disease >35
gestational wks
7 (14.3) 72 (15.5) 0.51
Table 4 Comparison of all collected data between
deceased and surviving septic neonates (univariate
analysis) (Continued)
Clinical course- and medical care-related
Reanimation required 45 (91.8) 294 (63.2) <0.0001
Mechanical ventilation required 37 (75.5) 123 (26.5) <0.0001
O2 inspiration fraction
>60 % required
23 (46.9) 72 (15.5) <0.0001
Continuous positive airway
pressure required
6 (12.2) 18 (3.9) 0.02
Surfactant administration 16 (32.7) 33 (7.1) <0.0001
Respiratory complication 1 (2.0) 34 (7.3) 0.13
Intraventricular bleeding 9 (18.4) 11 (2.4) <0.0001
Surgical procedure required 4 (8.2) 19 (2.2) 0.03
Invasive medical procedure required 48 (97.8) 245 (52.5) <0.0001
*Mean± Standard deviation (SD).
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most frequently isolated microorganisms [25]. Thus,
some authors have proposed classifying sepsis as a type
of transmission without taking temporality into consid-
eration; therefore, early-onset sepsis occurs by vertical
transmission and is mainly caused by Gram-negative
bacteria that are acquired before or after delivery, while
late-onset sepsis takes place by horizontal transmission
and is principally associated with Gram-positive bacteria
acquired after delivery; its source can be nosocomial- or
community-acquired [12,26,27]. Recently, Cooper C,
et al. reported that early-onset sepsis is defined within
48 h of births, although definitions in some studies in-
clude infection up to 72 h after birth, the health care
associated infections rarely occur within this period [28].
In the present work, the most frequently isolated micro-
organism for early- as well as late-onset sepsis was
Staphylococcus CoNS. Although this bacterium tends to
be normal flora of the skin, it has been suggested that it
can be pathogenic in newborns submitted to invasive
medical procedures (i.e., venous catherization, endo-
tracheal intubation, prematurity, and a prolonged
hospitalization period) [29-31].
It also has been described that Staphylococcus genus
CoNS is associated with inflammatory response evasion
[32,33]; resistance to antibiotics is measured by plasmids
[34] or quorum sensing [35,36]; it also possesses genetic
determinants such as operon-Catabolite activator pro-
tein (CAP) and the Gamma-glutamyl peptidase (GGP)
gene, which confers greater virulence on the bacterium
[37,38]. However, despite all of these virulence factors,
and although the hospital has certification in the quality
attention processing of patients; we are unable to discard
the possibility of contamination during venopuncture, or
the presence of microorganisms in moist environmental
near patient sources such as room temperature bubble
Table 5 Variables that retained statistical significance for
mortality in neonates with sepsis after Cox regression
model analysis
Variable HR 95 % CI P
Neonate-related
Prematurity (≤37 wks) 1.08 1.03-1.14 0.02
Low birth weight (≤2500 g) 1.04 1.01-1.08 0.01
Perinatal asphyxia 2.96 1.43-6.15 0.003
Apgar score ≤5 1.40 1.19-1.76 0.004
Clinical course- and medical care-related
Mechanical ventilation required 1.60 1.19-2.40 0.001
Surgical procedure required 2.85 1.49-5.46 0.002
Invasive medical procedure required 2.07 1.63-2.62 <0.0001
HR, Hazard ratio; 95 % CI, 95 % Confidence interval.
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guidelines for neonatal study recommendation defini-
tions, our findings should be interpreted in the context
of the quality of retrospective studies [21,39].
Prior studies have identified risk factors for sepsis such
as prematurity, low birth weight, premature membrane
rupture, maternal pyrexia, poor intra- and postpartum
hygiene, invasive medical procedures, and hospital stay
[3,13,40,41]. Likewise, in our study, sepsis-associated fac-
tors comprised prematurity, abnormal amniotic liquid,
premature membrane rupture, and invasive medical pro-
cedures such as mechanical ventilation, O2IF ≥60 %, re-
spiratory complication, and surgical procedure, as has
been described in previous studies [42,43] (Table 3). All
of these factors are present in early-onset sepsis; not-
withstanding this, in late-onset sepsis, we documented
additional factors such as postmaturity, multiple-
pregnancy product, perinatal asphyxia, and all invasive
therapeutic procedures (Table 3). It is noteworthy that in
this study, we documented that postmaturity is a late-
onset sepsis-associated factor (Relative Risk [RR] 7.7;
95 % CI, 1.4-35.7). In this context, Hákansson, et al.
reported that post-term infants with >42 weeks of gesta-
tional age had a 1.8 times greater risk of developing sep-
sis and pneumonia [44]; on the other hand; Cheng, et al.
documented that in neonates with >40 gestational
weeks, the risk of neonatal damage increases mainly due
to meconium aspiration (adjusted Odds ratio [OR], 1.27;
95 % CI, 1.17-1.37), which can condition sepsis develop-
ment [45]. More detailed studies are required that evalu-
ate the specific risk factors for post-term infants.
When we evaluated the clinical factors associated with
poor prognosis in 514 neonates with sepsis, we found
that prematurity, low birth weight, perinatal asphyxia,
and an Apgar score of ≤5, as well as invasive medical
procedures, are mortality-associated factors (Table 5).
These results are in agreement with previous reports
that associate these factors with poor prognosis anddeath in the neonate with infection [46-49]. Recently, it
has been documented that the incidence of pre-term
births (at <37 gestational wks) has increased in many
countries worldwide and that this represents a public
health problem because >70 % of pre-term infants are
found within the range of 34–36 gestational weeks (late-
onset pre-term). This is relevant because the majority of
epidemiological descriptions for neonatal sepsis are
directed toward or limited to neonates with very low
gestational age (<33 wks) or very low birth weight. Pre-
term neonates with late-onset sepsis are traditionally
treated by clinicians as full-term neonates; however,
there is evidence suggesting that pre-term neonates with
late-onset sepsis have a substantial increase in the risk
for morbi-mortality [20]. Cheng, et al. have reported that
neonates with 37 gestational weeks have a greater fre-
quency of a low Apgar of <7 at 5 min of life (adjusted
OR, 1.69; 95 % CI, 1.59-1.79) and a 5-min Apgar of <4
(adjusted OR, 1.87; 95 % CI, 1.63-2.15) with respect to
neonates born between 38 and 39 gestational weeks [45].
It has also been described that neonates of <37 weeks
have a greater risk of presenting respiratory complica-
tions and of consequently requiring mechanical ventila-
tion, which conditions them for greater susceptibility for
sepsis [49,50].
We also acknowledge some limitations of this work.
First, this study is of retrospective design, and this might
inevitably be complicated by incomplete data due to lost
records. Second, diagnoses were provided by different
caregivers. Unfortunately, ideal prospective data collec-
tion by designated study personnel proves extremely dif-
ficult in a developing country with limited resources.
Conclusions
In summary, the incidence of neonatal sepsis in south-
eastern Mexico was 4.3 % and early-onset sepsis was
more common in this population. A different risk profile
between early- and late-onset neonatal sepsis was found.
Poor outcome and mortality were mainly dependent on
prematurity, low birth weight, perinatal asphyxia, low
Apgar score, a requirement of assisted ventilation, and
invasive medical procedures.
Methods
Study design and population
We performed a retrospective cohort design using the
collected data of all newborns admitted to the Neonat-
ology Unit of the General Hospital and the High Spe-
cialty Medical Unit of the IMSS in Mérida, Mexico,
between 2004 and 2007. These medical facilities include
tertiary-care medical units at which nearby 1 million
persons receive specialized medical care annually. From
2004 to the present, in these medical wards, a prospect-
ive and comprehensive data collection was initiated that
Leal et al. BMC Pregnancy and Childbirth 2012, 12:48 Page 7 of 9
http://www.biomedcentral.com/1471-2393/12/48was focused on clinical and demographical newborn and
maternal features, in addition to hospital disease-
evolution data, which were recorded based on World
Health Organization (WHO) neonatal study recommen-
dation definitions [39]. All data are continuously regis-
tered and updated at the patient’s hospital discharge
despite the final outcome.
Neonatal sepsis definitions
As a routine procedure in the Neonatology Unit all neo-
nates having perinatal risk factors for sepsis must
undergo blood culture screening. Neonatal sepsis was
defined according to Pediatric Sepsis Consensus (PSC)
criteria [21]. Confirmed sepsis was defined as microbial
recovery from blood or any other biologic material cul-
ture in addition to the presence of a clinical or biological
syndrome of sepsis. For this study confirmed sepsis was
assessed from 1.0 ml peripherical blood with Peds
Plus/F culture vials processed by Bactec 9050 System
(Becton Dickinson, Inc., USA); since we selected only
blood culture, other body fluids such as CSF, pleural and
peritoneal fluid were excluded. A clinical and biological
syndrome of sepsis was considered despite having nega-
tive cultures when the neonate showed positive findings
on clinical examination or laboratory tests [e.g., body
temperature ≥38 °C o r ≥36 °C, high - sensitivity C react-
ive protein (CRP) levels ≥ 0.03 mg/dl, high or low
leukocyte count according to age (not related with
chemotherapy-induced leukopenia), or <10 % immature
neutrophils and blood pressure <2 Standard deviations
(SD) of the normal value according to age].
Collected data
Registered data were grouped into the following
domains:
Neonate-related: Gender; gestational age in week (wk),
weight in gram (g), and height in centimeter (cm) at de-
livery; prematurity; postmaturity; if the neonate was a
product of a multiple pregnancy; or if pathological um-
bilical cord and Apgar score were registered; or if the
neonate experienced perinatal asphyxia, intrauterine
hypoxia, or fetal distress;
Maternal-related: Mother’s age; educative level (≤6
low, 7–14 medium and≥ 15 professional); previous preg-
nancies, deliveries, or cesarean sections; if during the
pregnancy the mother received adequate monitoring, or
experienced threat of abortion; if the labor ended in dys-
tocic delivery and cesarean section; if placental or amni-
otic fluid abnormalities were registered; or if during the
pregnancy the mother had major infections, metabolic
disease, or preeclampsia-eclampsia (all of the three cate-
gorized as appearing before or after 35 weeks of gesta-
tion), or if the presence of premature membrane rupture
was detected;Clinical course and medical care-related: If neonatal
reanimation-assisted ventilation, O2IF ≥60 %, Continu-
ous positive airway pressure (CPAP), surfactant, or any
other invasive medical (such as pleural drainage, umbil-
ical tract, central venous catheterization, or parenteral
nutrition) or surgical procedure were required, or if the
neonate developed respiratory disease or intraventricular
bleeding.
Statistical analysis
In a first step, the risk for sepsis between neonates with
and without sepsis was assessed by mean unpaired Stu-
dent t test, Analysis of variance (ANOVA); Yates cor-
rected Χ2 test, or Fisher exact test, according the scale
type of the predictor variables. Subsequently, all vari-
ables exhibiting a p level ≤0.10 in univariate analysis
were entered (Forward Method) in a logistic regression
analysis in which Relative Risk (RR) and 95 % Confi-
dence Interval (95 % CI) were estimated. All statistical
analyses were performed using the statistical package
SPSS for Windows version 17.0).
Furthermore, we assessed the association between all
studied variables and death in neonates with sepsis. In
this case, all predictor variables having a p value ≤0.10
in univariate analysis were entered into a Cox propor-
tional hazard model in which the association indicator
was the Hazard ratio (HR) and its 95 % CI was also
obtained. Significance level was set at 0.05 in all analyses
performed.
Ethical issues
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